Published on February 1, 2021 on the LinkedIn network, by Isabelle Lecointre, company LyonMedCare


by Isabelle Lecointre of LyonMedCare

The vaccination campaign in France is based on respect for 3 principles: free, freedom and security . It should make it possible to protect caregivers , reduce the number of deaths caused by the virus and that of patients admitted to intensive care for serious forms of the disease.

As of January 30, 2021, 1,479,909 people were partially vaccinated, i.e. 2.21% the French. 45,468 people received the 2 doses of vaccine. France has received 2,653,200 doses since December 26, 2020.

Your attending physician will be able to help you in your consideration of this vaccination and these new types of vaccine for some of them.

  1. Which population groups are affected?

1.1. Currently, the 1st phase of vaccination, i.e. 1 million people, is represented by:

– people aged over 75,

– healthcare workers, firefighters, home helpers over 50 years old and/or suffering from co-morbidities (obesity; chronic obstructive pulmonary disease; respiratory failure; complicated arterial hypertension; heart failure; diabetes 1 and 2; chronic renal failure; cancers and malignant hematological diseases, active and less than 3 years old),

– people with disabilities housed in establishments and staff over 50 years old and/or suffering from Down syndrome,

– people suffering from a high-risk pathology: organ transplant recipients, rare diseases listed on the Ministry of Health list,

1.2. From March 2021, 2 phases are planned:

-2nd phase: people aged 65 to 74

-3rd phase: other sections of the population likely to be infected

2. Vaccination and pregnancy:

The Pfizer vaccine is not recommended during pregnancy unless for one reason or another the pregnant woman is at risk of developing a severe form of Covid-19. This question is obviously to be asked by each pregnant woman to the medical staff who support her during her pregnancy.

3. V accination and already sick with Covid:

The opinion of the attending physician should be sought before considering being vaccinated. A minimum period of 3 months must be respected after the onset of symptoms. Vaccination is not recommended if symptoms of the disease persist.

4. Time between vaccination against Covid and another vaccine:

A deadline of 3 weeks must be respected, normally.

5. How to make an appointment to get vaccinated?

by telephone at 0 800 009 110

par internet: 4 sites:; Doctolib; Keldoc; Maia

6. The different vaccines that exist and will soon be available:

  • COMIRNATY : manufactured by Pfizer – BioNTech (Germany): messenger RNA vaccine: must be stored at less than 80°C; for those over 16; 50% effective after the 1st injection and 95% effective after the 2nd injection; 2 injections 3 weeks apart
  • COVID – 19 Vaccine MODERNA (USA): messenger RNA vaccine: storage at minus 20°C; for those over 18; 94.5% effective; 2 injections 3 weeks apart
  • ASTRA-ZENECA (Great Britain): storage in a refrigerator; efficiency at 70.4%
  • SINOPHARM (China): effectiveness at 79.43%; storage between +2 and +8 degrees Celsius
  • SPUTNIK V (Russia): 2 injections; 92% efficiency; storage between +2 AND +8 degrees Celsius

174 vaccines are in the pre-clinical testing phase around the world and 63 others are in the clinical testing phases.

7. What are the differences between a conventional vaccine and a messenger RNA vaccine?

A classic vaccine is based on the use of a whole, inactivated virus or a part associated with an immunity adjuvant.

A messenger RNA vaccine is a type of vaccine that activates the adaptive immune system using messenger RNA whose nucleotide sequence encodes a protein identical to or similar to a pathogen antigen or tumor antigen. Ribonucleic acid is a chemical component present in almost all living things and also in certain viruses. This type of vaccine is recent: 1970s-1980s, it is used in the treatment of certain cancers.

8. The vaccination process:

  • before the injection, you will have administrative formalities to follow such as reading information about the vaccine injected with your signed consent for vaccination; the creation of your vaccination file with your social security number; completing a medical questionnaire seeking a history of allergy to vaccines or a list of injectable medications; the absence of infection or recent contact with Covid-19; the absence of temperature, autoimmune disease in flare-up, another vaccination less than 21 days old; a state of pregnancy or breastfeeding; anticoagulant treatment or bleeding problems,
  • a medical consultation if you answered yes to certain questions,
  • the injection of the vaccination and its traceability by the vaccinator,
  • post-vaccination monitoring lasting 15 minutes,
  • recording all the details of the vaccination and its progress in a Health Insurance database,
  • a 2nd vaccination appointment given before your departure with instructions in the event of the appearance of side effects and information on access to the processing of the data collected during this vaccination.

9. Post-vaccination adverse effects and their monitoring:

Just after the vaccine injection, caregivers monitor the appearance of significant allergies such as angioedema: difficulty breathing due to rapid swelling of the skin and mucous membranes in the head and neck. Treatment with an injection of medication should be undertaken immediately.

Other symptoms may appear more slowly and disappear in the days that follow: pain at the puncture site; a skin reaction at the injection area: redness, edema; headache; fatigue ; fever.

A 3rd type of symptoms can appear later or more intensely, such as lymph nodes. If this happens to you, tell your doctor or pharmacist. He or she will be able to make a computerized declaration of this incident to the pharmacovigilance center in your region. The address is: All reports are centralized and studied in depth at the level of the Ministry of Health.

Sources :